These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19336541)

  • 1. Absence of deleterious palladin mutations in patients with familial pancreatic cancer.
    Klein AP; Borges M; Griffith M; Brune K; Hong SM; Omura N; Hruban RH; Goggins M
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1328-30. PubMed ID: 19336541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism.
    Pogue-Geile KL; Chen R; Bronner MP; Crnogorac-Jurcevic T; Moyes KW; Dowen S; Otey CA; Crispin DA; George RD; Whitcomb DC; Brentnall TA
    PLoS Med; 2006 Dec; 3(12):e516. PubMed ID: 17194196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PALLD mutation in a European family conveys a stromal predisposition for familial pancreatic cancer.
    Liotta L; Lange S; Maurer HC; Olive KP; Braren R; Pfarr N; Burger S; Muckenhuber A; Jesinghaus M; Steiger K; Weichert W; Friess H; Schmid R; Algül H; Jost PJ; Ramser J; Fischer C; Quante AS; Reichert M; Quante M
    JCI Insight; 2021 Mar; 6(8):. PubMed ID: 33764904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The P239S palladin variant does not account for a significant fraction of hereditary or early onset pancreas cancer.
    Zogopoulos G; Rothenmund H; Eppel A; Ash C; Akbari MR; Hedley D; Narod SA; Gallinger S
    Hum Genet; 2007 Jun; 121(5):635-7. PubMed ID: 17415588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palladin mutation causes familial pancreatic cancer: absence in European families.
    Slater E; Amrillaeva V; Fendrich V; Bartsch D; Earl J; Vitone LJ; Neoptolemos JP; Greenhalf W
    PLoS Med; 2007 Apr; 4(4):e164. PubMed ID: 17455999
    [No Abstract]   [Full Text] [Related]  

  • 6. Familial pancreatic-cancer gene found.
    Bradbury J
    Lancet Oncol; 2007 Jan; 8(1):14. PubMed ID: 17348120
    [No Abstract]   [Full Text] [Related]  

  • 7. Polymorphism of the palladin gene and cardiovascular outcome in patients with atherosclerosis.
    Hoke M; Schillinger M; Dick P; Exner M; Koppensteiner R; Minar E; Mlekusch W; Schlager O; Wagner O; Mannhalter C
    Eur J Clin Invest; 2011 Apr; 41(4):365-71. PubMed ID: 21054356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Familial pancreatic cancer and the palladin gene: a new look at cancer mechanisms].
    Gilgenkrantz S
    Med Sci (Paris); 2007 Mar; 23(3):232-4. PubMed ID: 17349274
    [No Abstract]   [Full Text] [Related]  

  • 9. Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma.
    Shindo K; Yu J; Suenaga M; Fesharakizadeh S; Cho C; Macgregor-Das A; Siddiqui A; Witmer PD; Tamura K; Song TJ; Navarro Almario JA; Brant A; Borges M; Ford M; Barkley T; He J; Weiss MJ; Wolfgang CL; Roberts NJ; Hruban RH; Klein AP; Goggins M
    J Clin Oncol; 2017 Oct; 35(30):3382-3390. PubMed ID: 28767289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of germline BRCA1 mutations in familial pancreatic cancer patients.
    Axilbund JE; Argani P; Kamiyama M; Palmisano E; Raben M; Borges M; Brune KA; Goggins M; Hruban RH; Klein AP
    Cancer Biol Ther; 2009 Jan; 8(2):131-5. PubMed ID: 19029836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palladin is overexpressed in the non-neoplastic stroma of infiltrating ductal adenocarcinomas of the pancreas, but is only rarely overexpressed in neoplastic cells.
    Salaria SN; Illei P; Sharma R; Walter KM; Klein AP; Eshleman JR; Maitra A; Schulick R; Winter J; Ouellette MM; Goggins M; Hruban R
    Cancer Biol Ther; 2007 Mar; 6(3):324-8. PubMed ID: 17404500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial pancreatic cancer: hope can become truth.
    Pezzilli R; Fantini L
    JOP; 2007 Jan; 8(1):64-6. PubMed ID: 17228136
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families.
    Bartsch DK; Langer P; Habbe N; Matthäi E; Chaloupka B; Sina M; Hahn SA; Slater EP
    Clin Genet; 2010 Apr; 77(4):333-41. PubMed ID: 20041885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer.
    Martin ST; Matsubayashi H; Rogers CD; Philips J; Couch FJ; Brune K; Yeo CJ; Kern SE; Hruban RH; Goggins M
    Oncogene; 2005 May; 24(22):3652-6. PubMed ID: 15806175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families.
    Slater EP; Langer P; Fendrich V; Habbe N; Chaloupka B; Matthäi E; Sina M; Hahn SA; Bartsch DK
    Fam Cancer; 2010 Sep; 9(3):335-43. PubMed ID: 20195775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial pancreatic cancer: from genes to improved patient care.
    Hruban RH; Klein AP; Eshleman JR; Axilbund JE; Goggins M
    Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):81-8. PubMed ID: 19072437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer.
    Hu C; Hart SN; Polley EC; Gnanaolivu R; Shimelis H; Lee KY; Lilyquist J; Na J; Moore R; Antwi SO; Bamlet WR; Chaffee KG; DiCarlo J; Wu Z; Samara R; Kasi PM; McWilliams RR; Petersen GM; Couch FJ
    JAMA; 2018 Jun; 319(23):2401-2409. PubMed ID: 29922827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA2 mutations as a universal risk factor for pancreatic cancer has a limited role in Korean ethnic group.
    Cho JH; Bang S; Park SW; Chung JB; Song SY
    Pancreas; 2008 May; 36(4):337-40. PubMed ID: 18437078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEFV gene 3'-UTR Alu repeat polymorphisms in patients with familial Mediterranean fever.
    Ustek D; Ekmekçi C; Oku B; Coşan F; Cakiris A; Abaci N; Celik S; Kamali S; Hatemi G; Kasapçopur O; Ozdoğan H; Gül A
    Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S72-6. PubMed ID: 19026119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDKN2A germline mutations in familial pancreatic cancer.
    Bartsch DK; Sina-Frey M; Lang S; Wild A; Gerdes B; Barth P; Kress R; Grützmann R; Colombo-Benkmann M; Ziegler A; Hahn SA; Rothmund M; Rieder H
    Ann Surg; 2002 Dec; 236(6):730-7. PubMed ID: 12454511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.